Nevro Corp (N:NVRO)

Business Focus: Medical Equipment, Supplies & Distribution

Sector:  Healthcare Industry:  Medical Equipment, Supplies & Distribution
 
See Regulatory Filings on SEC
Company Contact
Address: 1800 Bridge Parkway
REDWOOD CITY CA 94065
Tel: N/A
Website: https://www.nevro.com
IR: See website
<
Key People
D. Keith Grossman
Executive Chairman of the Board
Greg Siller
Senior Vice President, Chief Commercial Officer
Kevin R. Thornal
President, Chief Executive Officer, Director
Roderick H. Macleod
Chief Financial Officer, Senior Vice President
Lori Ciano
Chief Human Resource Officer, Senior Vice President
Kashif Rashid
Senior Vice President, General Counsel, Company Secretary
David Caraway
Senior Vice President, Chief Medical Officer
Christopher Christoforou
Senior Vice President - Technical Operations
Donald A. Middlebrook
Senior Vice President - Clinical, Regulatory and Quality
Jon R. Shear
Senior Vice President - Corporate Development
   
Business Overview
Nevro Corp. is a global medical device company. The Company is focused on delivering solutions that continue to set the standard for enduring patient outcomes in chronic pain treatment. Its comprehensive HFX spinal cord stimulation 3 (SCS) platform includes the Senza SCS system and support services for the treatment of chronic pain of the trunk and limb and painful diabetic neuropathy. It has developed and commercialized its HFX spinal cord stimulation (SCS) platform, which includes the Senza SCS system, an evidence-based neuromodulation system for the treatment of chronic pain, with the Senza HFX iQ platform. Its HFX solution delivers a range of waveforms, including its paresthesia-free 10 kHz Therapy. Its 10 kHz Therapy is designed to deliver neuromodulation solutions for treating chronic pain. Its products include Senza II SCS System, Senza Omnia SCS System, Senza Omnia upgrade, Omnia Powered by HFX Connect, Senza HFX iQ System, and Surpass Surgical Lead.
Financial Overview
For the fiscal year ended 31 December 2023, Nevro Corp revenues increased 5% to $425.2M. Net loss totaled $92.2M vs. income of $3M. Revenues reflect United States segment increase of 5% to $366.6M, International segment increase of 1% to $58.6M. Net loss reflects Certain litigation charges decrease from $105M (income) to $0K, Selling/General/Admin. Expense - Balanci increase of 5% to $290.2M (expense).
Employees: 1,215 as of Dec 31, 2023
Reporting Currency: U.S. Dollars
Enterprise value: $331.49M as of Dec 31, 2023
Annual revenue (TTM): $425.17M as of Dec 31, 2023
EBITDA (TTM): -$90.16M as of Dec 31, 2023
Net annual income (TTM): -$92.21M as of Dec 31, 2023
Free cash flow (TTM): -$67.42M as of Dec 31, 2023
Net Debt Last Fiscal Year: N/A
Shares outstanding: 36,681,392 as of Mar 28, 2024
TTM: Trailing Twelve Months
EBITDA: Earnings Before Interest, Taxes, Depreciation, & Amortization

Thank you for visiting InsiderTracking.com. We have detected you cannot see ads being served on our site due to blocking. Unfortunately, due to the high cost of data, we cannot serve the requested page without the accompanied ads.

If you wish to consider using a browser that blocks ads, please log in or subscribe.

Alternatively, if you have installed ad-blocking software, please disable it (sometimes a complete uninstall is necessary). If you are in private browsing mode and do not want to subscribe, please disable tracking protection while visiting our website.

Thank you for using Insider Tracking.